HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $83.30 billion. The enterprise value is $124.27 billion.
| Market Cap | 83.30B |
| Enterprise Value | 124.27B |
Important Dates
The next confirmed earnings date is Friday, April 26, 2024, before market open.
| Earnings Date | Apr 26, 2024 |
| Ex-Dividend Date | Mar 14, 2024 |
Share Statistics
HCA Healthcare has 264.49 million shares outstanding. The number of shares has decreased by -6.19% in one year.
| Shares Outstanding | 264.49M |
| Shares Change (YoY) | -6.19% |
| Shares Change (QoQ) | -1.56% |
| Owned by Insiders (%) | 27.22% |
| Owned by Institutions (%) | 64.63% |
| Float | 191.28M |
Valuation Ratios
The trailing PE ratio is 16.69 and the forward PE ratio is 15.29. HCA Healthcare's PEG ratio is 1.44.
| PE Ratio | 16.69 |
| Forward PE | 15.29 |
| PS Ratio | 1.29 |
| Forward PS | 1.20 |
| PB Ratio | n/a |
| P/FCF Ratio | 17.86 |
| PEG Ratio | 1.44 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.47, with an EV/FCF ratio of 26.51.
| EV / Earnings | 23.71 |
| EV / Sales | 1.91 |
| EV / EBITDA | 10.47 |
| EV / EBIT | 14.13 |
| EV / FCF | 26.51 |
Financial Position
The company has a current ratio of 1.18
| Current Ratio | 1.18 |
| Quick Ratio | 0.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.50 |
| Debt / FCF | 8.85 |
| Interest Coverage | 4.54 |
Financial Efficiency
Return on equity (ROE) is -231.70% and return on invested capital (ROIC) is 18.53%.
| Return on Equity (ROE) | -231.70% |
| Return on Assets (ROA) | 9.70% |
| Return on Capital (ROIC) | 18.53% |
| Revenue Per Employee | $209,574 |
| Profits Per Employee | $16,910 |
| Employee Count | 310,000 |
| Asset Turnover | 1.20 |
| Inventory Turnover | 19.27 |
Taxes
In the past 12 months, HCA Healthcare has paid $1.62 billion in taxes.
| Income Tax | 1.62B |
| Effective Tax Rate | 23.55% |
Stock Price Statistics
The stock price has increased by +19.01% in the last 52 weeks. The beta is 1.67, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (1Y) | 1.67 |
| 52-Week Price Change | +19.01% |
| 50-Day Moving Average | 319.57 |
| 200-Day Moving Average | 278.29 |
| Relative Strength Index (RSI) | 46.67 |
| Average Volume (30 Days) | 1,068,083 |
Short Selling Information
The latest short interest is 2.60 million, so 0.98% of the outstanding shares have been sold short.
| Short Interest | 2.60M |
| Short Previous Month | 2.65M |
| Short % of Shares Out | 0.98% |
| Short % of Float | 1.36% |
| Short Ratio (days to cover) | 2.61 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $64.97 billion and earned $5.24 billion in profits. Earnings per share was $18.97.
| Revenue | 64.97B |
| Gross Profit | 25.58B |
| Operating Income | 9.63B |
| Pretax Income | 6.86B |
| Net Income | 5.24B |
| EBITDA | 11.87B |
| EBIT | 8.80B |
| Earnings Per Share (EPS) | $18.97 |
Balance Sheet
The company has $935.00 million in cash and $41.50 billion in debt, giving a net cash position of -$40.56 billion or -$153.36 per share.
| Cash & Cash Equivalents | 935.00M |
| Total Debt | 41.50B |
| Net Cash | -40.56B |
| Net Cash Per Share | -$153.36 |
| Equity / Book Value | -1.77B |
| Book Value Per Share | -6.71 |
| Working Capital | 2.27B |
Cash Flow
In the last 12 months, operating cash flow was $9.43 billion and capital expenditures -$4.74 billion, giving a free cash flow of $4.69 billion.
| Operating Cash Flow | 9.43B |
| Capital Expenditures | -4.74B |
| Free Cash Flow | 4.69B |
| FCF Per Share | $17.21 |
Margins
Gross margin is 39.37%, with operating and profit margins of 14.82% and 8.07%.
| Gross Margin | 39.37% |
| Operating Margin | 14.82% |
| Pretax Margin | 10.55% |
| Profit Margin | 8.07% |
| EBITDA Margin | 18.27% |
| EBIT Margin | 13.54% |
| FCF Margin | 7.21% |
Dividends & Yields
This stock pays an annual dividend of $2.64, which amounts to a dividend yield of 0.84%.
| Dividend Per Share | $2.64 |
| Dividend Yield | 0.84% |
| Dividend Growth (YoY) | 7.89% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 13.92% |
| Buyback Yield | 6.19% |
| Shareholder Yield | 7.03% |
| Earnings Yield | 6.26% |
| FCF Yield | 5.60% |
Analyst Forecast
The average price target for HCA Healthcare is $316.10, which is 0.40% higher than the current price. The consensus rating is "Buy".
| Price Target | $316.10 |
| Price Target Difference | 0.40% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 5.34% |
| EPS Growth Forecast (5Y) | 9.64% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.6 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.6 |
| Piotroski F-Score | 8 |